One foundation's strategy to accelerate drug discovery through genomics.
Where this comes from
- Record sourced from PubMed, PMID 21490273.
- Also identified by DOI 10.1126/scitranslmed.3002440.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The Multiple Myeloma Research Foundation (MMRF) has the principal goal of accelerating development of next-generation drugs for treating multiple myeloma. By making targeted investments in key research areas such as genomics and epigenetics, the MMRF is helping to elucidate the basic biology of multiple myeloma, to drive promising new treatments into clinical development, and ultimately to link the right treatment to the right patient.
Medical subject headings
- Drug Discovery
- Foundations
- Genomics